Seizures in the elderly: Development and validation of a diagnostic algorithm

Epilepsy Research

Volumn 89, Issue 2-3, 2010, Pages 339-348

  Dupont, Sophie ^a,b   Verny, Marc ^a   Harston, Sandrine ^c   Cartz Piver, Leslie ^d   Schück, Stéphane ^e   Martin, Jennifer ^e   Puisieux, François ^f   Alecu, Cosmin ^g   Vespignani, Hervé ^g   Marchal, Cécile ^c   Derambure, Philippe ^f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d Neurology Department   (France)

^e Kappa Sante   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Epilepsy, Elderly, Diagnostic algorithm

Indexed keywords

AGED; ALGORITHM; ARTICLE; AUTOMATISM; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CONFUSION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMAGING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SEIZURE; SENSITIVITY AND SPECIFICITY; SYNCOPE; TRANSIENT GLOBAL AMNESIA; TRANSIENT ISCHEMIC ATTACK; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; AGING; ALGORITHMS; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951294823     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.02.008     Document Type: Article

References (67)

1. Alore P., Schneck M., Macken M. Use of levetriacetam in an elderly hospital-based patient population. Epilepsia 2005, 46:168.
2. Alsaadin T., Koopmans S., Apperson M., Farias S. Levetiracetam monotherapy for elderly patients with epilepsy. Seizure 2004, 13:58-60.
3. Arroyo S., Kramer G. Treating epilepsy in the elderly. Safety considerations. Drug Saf. 2001, 24:991-1015.
4. Aukakh J., Hawkins J., Athwal H., Sheikh J., Yesavage J., Tinklenberg J. Tolerability and effectiveness of lamotrigine in complex elderly patients. J. Geriatr. Psychiatry Neurol. 2005, 18:8-11.
5. Bergey G. Initial treatment of epilepsy. Special issues in treating the elderly. Neurology 2004, 63:S40-S48.
6. Biton V. Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy. Expert Opin. Drug Metab. Toxicol. 2006, 2:1009-1018.
7. Brodie M.J., Overstall P., Giorgi L. Multicentre, double-blid, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res. 1999, 37:81-87.
8. Derambure P., Verny M. Crises épileptiques survenant de novo chez des patients âgés de plus de 65 ans. Résultats préliminaires de l'observatoire CEPAGE. La Revue de Gériatrie 2006, 31:B1-B4.
9. Di Bonaventura C., Mari F., Fattouch J., Egeo G., Vaudano A., Manfredi M., et al. Use of levetiracetam in treating epilepsy associated with other medical conditions. Acta Neurol. Scand. 2006, 113:82-86.
10. Excellence NIfC, 2004. The Epilepsies. The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care. Clinical Guideline 20. National Institute for Clinical Excellence, pp. 6-64.
11. Fakhoury T., Miller J., Hammer A., Vuong A. An evaluation of lamotrigine on mood in older adults with epilepsy and comorbid depressive symptoms. Epilepsia 2005, 46:174.
12. Faught E. Epidemiology and drug treatment of epilepsy in elderly people. Drug Aging 1999, 15:255-269.
13. Ferrendelli J., French J., Leppik I., Morrell M., Herbeuval A., Han J., et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behav. 2003, 4:175-180.
14. French J. Use of levetiracetam in special populations. Epilepsia 2001, 42:40-43.
15. Garnett W. Optimizing antiepileptic drug therapy in the elderly. Ann. Pharmacother. 2005, 39:1852-1860.
16. Gil-Nagel A. Gabapentin in the treatment of epilepsy in the elderly. Rev. Neurol. 2002, 34:391-396.
17. Groselj J., Guerrini R., Van Oene J., Lahaye M., Schreiner A., Schwalen S., et al. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy. Acta Neurol. Scand. 2005, 112:144-150.
18. Gueguen B., Vetel J. Epilepsie du sujet âgé: diagnostic et traitement. L'année Gérontologique 2000, 14:313-328.
19. Hauser W.A. Epidemiology of Seizures and Epilepsy in the Elderly 1997, 7-18. Butterworth-Heinemann, Boston. A.J. Rowan, R.E. Ramsay (Eds.).
20. Hirschorn K., Chabolla D., Bortz J., Sirven J. The necessity of video-EEG monitoring in older adults. Part III. Physiologic nonepileptic seizures in later life. Epilepsia 2001, 42:142.
21. Jallon P., Perrig S. Médicaments, crises épileptiques et épilepsie. Revue médicale de la Suisse romande 2003, 123:11-15.
22. Johnson J., Prior F., Ramsay E., Rowan J., DeToledo J. Recruitment of elderly patients in clinical trials. Epilepsia 2001, 42:142.
23. Karceski S., Morrell M., Carpenter D. The expert consensus guideline series. Treatment of epilepsy. Epilepsy Behav. 2001, 2:A1-A50.
24. Kraemer G., Edrich P. Levetiracetam in elderly patients with epilepsy. Epilepsia 2001, 42:142.
25. Kustra R., Hammer A., Messenheimer J. Evaluation of lamotrigine as adjunctive and monotherapy in elderly patients with epilepsy: a subanalysis of a large observational study. Epilepsia 2002, 43:194.
26. Kutluay E., McCague K., D'Souza J., Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003, 4:175-180.
27. Leppik I. Choosing an antiepileptic. Selecting drugs for older patients with epilepsy. Geriatrics 2005, 60:42-47.
28. Leppik I., Birnbaum A. Epilepsy in the elderly. Semin. Neurol. 2002, 22:309-319.
29. Leppik I., Bergey G., Ramsay E., Rowan A., Gidal B., Birnbaum A., et al. Advances in antiepileptic drug treatments. A rational basins for selecting drugs for older patients with epilepsy. Geriatrics 2004, 59:14-24.
30. Leppik I., Brodie M., Saetre E., Rowan A., Ramsay R., Jacobs M. Outcomes research: clinical trials in the elderly. Epilepsy Res. 2006, 68:S71-S76.
31. Li X., Breteler M., De Bruyne M., Meinardi H., Hauser W.A., Hofman A. Vascular determinants of epilepsy: the Rotterdam study. Epilepsia 1997, 38:1216-1220.
32. Lott R. Lamotrigine: treatment of epilepsy in the elderly. Consultant Pharm. 2003, 18:979-992.
33. Malmgren K., Flink R., Guekht A., Michelucci R., Neville B., Pedersen B., et al. Special report - ILAE Commission of European Affairs Subcommission on European Guidelines 1998-2001; the provision of epilepsy care across Europe. Epilepsia 2003, 44:727-731.
34. Mann M. Prise en charge de la première crise épileptique. La Revue du Praticien 2005, 55:265-270.
35. Mauri Llerda J., Tejero C., Mercade J., Padro L., Salas Puig J. Lamotrigine and epilepsy in the elderly: observational study of low-dose monotherapy. Int. J. Clin. Pract. 2005, 59:651-654.
36. Mehta S., Pryor F., Rowan A., Uthman B., Ramsay R. Tolerability and efficacy of topiramate in older patients. Epilepsia 2001, 42:143.
37. Mehta S., Pryor F., Kraut L., Hulihan J., Ramsay R. Efficacy and tolerability of topiramate in the elderly population. Epilepsia 2002, 43:165.
38. Miskov S., Roje Bedekovi M., Mikula I., Demarin V. Etiology and treatment of epilepsy in the elderly. Acta Med. Croat. 2005, 59:63-67.
39. Morrell M. Differential diagnosis of seizures. Neurol. Clin. 1993, 11:737-754.
40. Morrell M., Mac lean M., Willmore L., Privitera M., Faught R., Holmes G., et al. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. Seizure 2000, 9:241-248.
41. Network SIG, 2003. Diagnosis and Management of Epilepsy in Adults. A National Clinical Guideline, pp. 1-49.
42. Nieto-Barrera M., Brozmanova M., Capovilla G., Christe W., Pedersen Kane K., O'Neill F., et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 2001, 46:145-155.
43. Payakachat N., Summers K., Barbuto J. A comparison of clinical practice guidelines in the initial pharmacological management of new-onset epilepsy in adults. J. Manage. Care Pharm. 2006, 12:55-60.
44. Pedersen B. Epilepsy in the elderly: the use of tiagabine. Epilepsia 2001, 42:52-54.
45. Perruca E. Pharmacokinetic variability of new antiepileptic drugs at different ages. Drug Monit. 2005, 27:714-717.
46. Perruca E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clin. Pharmacokinet. 2006, 45:351-363.
47. Poza-Aldea J. Epilepsy in the elderly. Rev. Neurol. 2006, 42:42-46.
48. Ramsay R., Pryor F. Epilepsy in the elderly. Neurology 2000, 55:S9-S14.
49. Ricci S., Celani M., Righetti E. Development of clinical guidelines: methodological and practical issues. Neurol. Sci. 2006, 27:S228-S230.
50. Rowan A. Epilepsy in older adults. Common morbidities influence development, treatment strategies, and expected outcomes. Geriatrics 2005, 60:30-34.
51. Rowan J., Ramsay R., Pryor F., Collins J., Point P. Seizures in the elderly population: interim report of VA cooperative study 428. Epilepsia 2001, 42:1868-1873.
52. Rowan A.J., Ramsay R., Collins J., Pryor F., Boardman K., Uthman B., et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005, 64:1868-1873.
53. Ruggles K., Haessly-Ruggles S. Late-onset seizures. Epilepsia 2001, 42:143.
54. Saetre E., Perruca E., Isojarvi J., Gjerstad L. An international multicenter double-blind randomised comparative trial of lamotrigine and slow release carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsia 2005, 46:216. Group tLS.
55. Scherer A. New guidelines on the treatment of epilepsy with the new antiepileptic drugs. From the Epilepsy Foundation. Epilepsy Behav. 2004, 5:433-434.
56. Semah F., Picot M., Derambure P., Dupont S., Vercueil L., Chassagnon S., et al. The choice of antiepileptic drugs in newly diagnosed epilepsy: a national French survey. Epileptic Disord. 2004, 6:255-265.
57. Sierzant T., Schachter S., Robbertz A. Epilepsy in seniors: knowledge and practice patterns among 221 health care providers: an epilepsy foundation study. Epilepsia 2005, 46:363-364.
58. Sirven J., Ozuna J. Diagnosing epilepsy in older adults. What does it mean for the primary care physician?. Geriatrics 2005, 60:30-35.
59. Statements C, 1998. Medical Management of Epilepsy. Neurology 51, S39-S43.
60. Thomas, P., 2004. Conférence de consensus, texte des experts. Conduite du traitement par les antiépileptiques au long cours dans les épilepsies partielles pharmacorésistantes de l'adulte. Rev. Neurol. 160, 5S252-5S264.
61. Thomas P., Beaumanoir A., Genton P., Dolisi C., Chatel M. De novo absence status of late onset: report of 11 cases. Neurology 1992, 42:104-110.
62. Tosches W., Tisdell J. Long-term zonisamide therapy in geriatric patients: efficacy and safety. Epilepsia 2005, 46:190.
63. Trinka E. Epilepsy: comorbidity in the elderly. Acta Neurol. Scand. 2003, 108:33-36.
64. Van Cott A. Epilepsy and EEG in elderly. Epilepsia 2002, 43:94-102.
65. Vespignani H. Les épilepsies du sujet âgé. Neurologies 2004, 7:163-190.
66. Wallace H., Shorvon S., Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998, 352:1970-1973.
67. Waterhouse E., DeLorenzo R. Status epilepticus in older patients. Epidemiology and treatment options. Drug Aging 2001, 18:133-142.